Shibani Pati, MD, PhD

I am currently the Director of the Center for Research Transfusion Medicine and Cell Therapies (CTMCT). My main goal is to foster multidisciplinary collaborations that advance the fields of transfusion medicine (TM) and cellular therapeutics (CT). My lab's research is focused on the role of endothelial dysfunction and vascular compromise in the pathogenesis of human disease. My specific areas of investigation involve the use of stem cells and novel resuscitative modalities, including blood products, that can mitigate endothelial dysfunction or the endotheliopathy of trauma (EOT) in traumatic injury.

I am also the main organizer of  CTTACC- Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Medicine Conference. We have now organized and hosted five conferences that have been focused upon cellular therapies in trauma and critical care. The website for the meeting is www.cttacc.org. The next CTTACC conference is scheduled for May 4-7, 2025 in Scottsdale, AZ. The conference is co-hosted by Colorado State University and The Armed Forces Institute of Regenerative Medicine (AFIRM).The goal of this meeting is to bring together the expertise and input of blood bankers, clinicians running trials, basic scientists, companies, FDA, NIH, AABB, BARDA, ISCT, ARPA-H, and the DOD  to discuss existing barriers in the translation of cell therapies in trauma and critical care medicine, a field with few therapeutic options. This year's conference will have a Military Health session focused on the prolonged field care of combat casualties.